Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate BMD Effects in Breast Cancer
NCT00213980Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2000
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronate in breast cancer, sponsored by University of Wisconsin–Madison. Started Jan 2000; status: completed.
02
Drugs
zoledronate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00213980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213980.